Abstract Dobrava (DOBV) and Puumala (PUUV) viruses are endemic throughout the Balkans and cause haemorrhagic fever with renal syndrome (HFRS). The aim of this study was to assess the impact of two different hantaviruses on renal function in HFRS patients during the acute stage of illness. We also aimed to assess the DOBV and PUUV distribution between symptomatic HFRS patients and asymptomatic hantavirus antibody-positive subjects. The study included 264 symptomatic HFRS patients and 63 asymptomatic hantavirus antibody-positive healthy subjects. In our study, 131 (49.6%) HFRS patients were regarded as PUUV-and 69 (26.1%) as DOBV-infected patients, while in 64 (24.2%) of HFRS patients that showed all clinical and biochemical signs of HFRS, the causal hantavirus could not be determined with commercially available tests. DOBVinfected patients were associated with more requirements for haemodialysis treatment, lower diuresis and higher serum creatinine and urea values compared to PUUV-infected patients. PUUV was significantly predominant in asymptomatic hantavirus antibody-positive subjects (69.8%) compared to HFRS patients. DOBV was present in 17.5% of asymptomatic subjects and, interestingly, the preferential hantavirus serotype could not be determined in 12.7% of the asymptomatic antibody-positive subjects.
Introduction
Hantaviruses (family Bunyaviridae, genus Hantavirus) are enveloped RNA viruses, carried primarily by rodents or insectivores of specific host species. Three hantaviruses, Puumala (PUUV), Dobrava (DOBV) and Saaremaa (SAAV), are known to cause haemorrhagic fever with renal syndrome (HFRS) in Europe [1] . HFRS is a febrile illness which generally involves haemostatic and renal disturbances. The clinical picture of HFRS is highly variable, from asymptomatic to fatal. DOBV-induced infections carry a considerable mortality, whereas diseases caused by PUUV and SAAVare less severe [2] . The most severe form of HFRS is caused by Hantaan virus (HTNV) in Asia and DOBV in the Balkans, with a mortality rate from 3% to 12%. PUUV, the most prevalent hantavirus, causes the mild form of HFRS through central and northern Europe, the Russian Federation and the Balkans, with a mortality rate from 0.1% to 0.4% [3, 4] . The causes of the differences in clinical severity are unknown; it may involve the virulence of individual viral strains, the infective dose or host factors.
Bosnia and Herzegovina (B&H) has been recognised as a highly endemic region for hantavirus infections for over 50 years [5] . Several HFRS outbreaks in B&H have been reported [5] [6] [7] [8] . During the war in B&H (1995), more than 300 patients, mostly soldiers from northeast Bosnia, were hospitalised with acute hantavirus disease due either to PUUV or DOBV as first documented by IgG and IgM enzyme-linked immunosorbent assay (ELISA) [9] and later confirmed by focus reduction neutralisation tests [10] .
The target organ for PUUV and DOBV is the kidney, but the impact on renal function seems to be far more important in DOBV than in PUUV infections. Hukić et al. [11] investigated renal failure and capillary leakage in 50 patients with serologically confirmed DOBV and PUUV infection admitted to the hospital during the HFRS outbreak in B&H and found that DOBV was associated with the more severe renal function disorders compared to PUUV infection. In a recently published study from B&H by Tulumovic et al. [12] , renal function was analysed during the acute phase and long-term consequences in 53 DOBVand 82 PUUV-infected patients who have been admitted to the hospital during the HFRS outbreak of 1995. A more severe renal impairment was observed in DOBV-compared to PUUV-infected patients during the acute phase. Follow up of the patients after 10 years indicated that the glomerular filtration rate, although within normal range, was significantly lower in DOBV compared to PUUV patients. Reports from Croatia and Slovenia where PUUV and DOBV also coexist suggested that DOBV-infected patients exhibited significant differences in illness severity [13] [14] [15] [16] . DOBV-infected patients suffered more frequently from acute renal failure requiring dialysis treatment, shock, visual disturbances, severe thrombocytopaenia, haemorrhagic complications and disseminated intravascular coagulation than patients with PUUV infection [17] .
The aim was to also compare the differences in renal impairment in DOBV-and PUUV-infected patients with HFRS during the acute stage of illness admitted to the hospital during the period from 1998 to 2002. We also aimed to compare the DOBV and PUUV distribution between symptomatic HFRS patients and asymptomatic hantavirus antibody-positive subjects.
Methods

Subjects
The study was designed as a retrospective review of existing clinical records for 264 patients with serologically confirmed HFRS. The patients were admitted within the average of 15.7±9.2 days post-onset-of-symptoms (POS) to the university-based tertiary centres in B&H during the period 1998-2005. The patient's kidney function was assessed at the internal medicine departments where they were followed up and received treatment. Exclusion criteria were the patients with the mild form of the disease who were not admitted to the hospitals and history of potentially nephrotoxic drugs abuse. The mean age of the HFRS patients was 33.5±10.65 years and there were 241 (91.3%) males and 23 (8.7%) females (male/female [M/F] ratio: 10.48).
The study also included 1,381 asymptomatic healthy volunteers without previous history of symptoms related to HFRS who attended health care centres for various reasons from 2000 to 2006. The subjects were selected randomly both from rural and urban areas and different regions of B&H. The mean age of asymptomatic subjects was 43.5± 14.8 years and there were 746 females and 635 males (M/F ratio: 1.17). Sera from asymptomatic subjects were taken according to the ethical regulations in B&H and written informed consent was obtained from all participants included in the study. Serological tests revealed that 63 (4.6%) asymptomatic subjects were hantavirus antibodypositive and these were later included in the analysis.
Measurements
In HFRS patients, we assessed the requirement for haemodialysis treatment, number of haemodialysis treatments, 24-h diuresis, the presence of haematuria and urine opalescence. We also measured the serum urea and creatinine levels during the acute stage of illness. Twentyfour-hour diuresis was assessed every day throughout the acute phase and the lowest 24-h diuresis values were taken for the analysis. The serum urea and creatinine concentration was measured on the Dimension Clinical Chemistry System (Dade Behring).
Serum samples from HFRS patients were taken in duplicate up to 20 to 40 days POS. Serum samples were examined for the presence of hantaviral antibodies using IgM and IgG ELISA tests reactive with DOBV, PUUV, HTNV and Seoul (SEOV) viruses followed by the Western blot (WB) test. Serum samples from asymptomatic subjects were examined for the presence of hantavirus antibodies by applying IgG ELISA tests and the WB test.
IgG and IgM enzyme-linked immunoassay
Hantavirus IgM and IgG antibodies were detected using a commercially available ELISA kit (Focus Technologies, California, USA). The Focus kit uses a pool of baculovirus recombinant N-truncated protein from several hantaviruses as the antigen. The manufacturer's protocol was followed. Briefly, serum samples from patients were diluted 1:100 in duplicate and incubated for 1 h at room temperature in antigen-coated, 96-well plates. Peroxidase-coupled antihuman IgG or IgM was used as the secondary antibody, and was incubated for 30 min at room temperature. The substrate was added and colour development was assessed by measuring the absorbance at 450 nm. The average of both absorbance values had to be ≥1,100 for a sample to be considered as positive.
Bunyavirus immunoblot
All serum samples were additionally analysed applying the Bunyavirus immunoblot IgG test (Microgen, Munich, Germany). The Bunyavirus immunoblot test contains recombinant antigens, i.e. combined PUUV + HTNV antigens, separate antigens of PUUV, HTNV, DOBV and SEOV antigen.
Patients were considered to be PUUV-infected when there was a preferential reaction with PUUV antigen in ELISA and if-in the WB test-a reaction to the combined PUUV/HTNV and to the separate PUUV antigen was noted. Similar criteria were applied for DOBV infection be it that there were noted reactions against HTNV/DOBV antigens.
Patients were considered to be non-identified hantavirus patients when-in ELISA and WB-there was an equal reaction to several (PUUV, HTNV, DOBV) antigens.
Statistical analysis
The data are presented as percentages or as the mean ± standard deviation (SD). Differences in proportions were tested using the Chi-square test or Fisher's exact test where appropriate. The difference in continuous variables between the groups was tested with Student's t-test. All analyses were performed using the SPSS for Windows software (version 16.0, SPSS Inc., Chicago, IL, USA).
Results
The distribution of hantavirus serotypes in 264 symptomatic HFRS patients and in 63 asymptomatic hantavirus antibody-positive subjects is shown in Table 1 . In HFRS patients, PUUV accounted for 49.6% and DOBV for 26.1% of seropositive patients, while in asymptomatic subjects, PUUV was detected in 44 (69.8%) of the subjects and was significantly more prominent compared to the symptomatic subjects (χ 2 =8.5; p=0.014). DOBV was detected in 11 (17.5%) hantavirus antibody-positive asymptomatic subjects.
In 24.2% of the symptomatic HFRS patients, the hantavirus serotype could not be defined. Interestingly, also in hantavirus antibody-positive asymptomatic subjects, there were eight (12.7%) subjects in whom we could not define a specific hantavirus serotype (Table 1) .
Haemodialysis treatment was required in 18 (6.9%) of the HFRS patients ( Table 2 ). Haemodialysis treatment was more frequently required by DOBV-infected compared to PUUV-and non-identified hantavirus-infected patients (χ 2 =10.71; p=0.005) ( Table 2 ). The majority of the haemodialysed patients (58.8%) underwent two or fewer haemodialysis treatments, 29.4% underwent three, four or five treatments, while 11.8% of the patients required six or more treatments. The number of haemodialysis treatments was not associated with the infecting hantavirus serotype (χ 2 =3.6; NS). The mean diuresis value was significantly lower (335.9± 100.5 mL/day) in DOBV compared to PUUV (615.2± 142.7 mL/day; p=0.007) and non-identified hantavirus antibody-positive (400.0±42.0 mL/day; p=0.016) patients, while no significant differences in the mean diuresis values between PUUV and non-identified hantavirus-seropositive subjects were found (Table 2 ). In DOBV-infected patients, the mean serum creatinine (610.0±433.1 μmol/L) and urea (25.4± 13.6 mmol/L) values were significantly higher compared to PUUV-infected patients (p<0.05), while no significant differences in the mean serum creatinine and urea concentration between DOBV and non-identified hantavirus-infected patients were observed (Table 2) . Haematuria was observed in 90% of DOBV patients, in 75.8% of PUUV patients and in 69.6% of non-identified hantavirus patients. Opalescent urine was observed in all DOBV-infected patients (100%), in 84.3% of PUUV-infected patients and in 87.0% of non-identified hantavirus-infected patients.
Discussion
Our study findings show the circulation of PUUV and DOBV in HFRS patients in B&H. PUUV and DOBV antibodies were detected in 49.6% and 26.1% of the HFRS patients in our study, respectively. In asymptomatic hanta- virus antibody-positive subjects, the PUUV seroreactivity was significantly more prevalent in asymptomatic subjects compared to HFRS patients, which suggests that PUUV is less virulent and that PUUV causes inapparent or mild infection not necessitating hospitalisation. Our study demonstrated that acute renal failure was more frequent in DOBV-seropositive patients during the acute stage of hantavirus infection. In HFRS patients who underwent haemodialysis treatment due to hantavirusinduced acute renal failure, a significant predominance of DOBV-seropositive subjects (61.1%) was observed. Also, DOBV-seropositive patients in our study had more severe renal impairment compared with the PUUV and nonidentified hantavirus-positive patients as witnessed by the diuresis, serum urea and creatinine values during the acute stage of the illness. Our results are in line with previous reports from B&H, Croatia and Slovenia that associated DOBV with severe forms of HFRS [13] [14] [15] [16] [17] .
In a recently published study, Tulumovic et al. [12] analysed the clinical course and the outcome of 135 HFRS patients admitted to the hospital during the outbreak in 1995 in B&H. The authors found that DOBV-seropositive patients had higher creatinine level, were frequently anuric, dialysis-dependant and hypotensive compared to PUUV patients. In a study by Hukić et al. [11] , diuresis, serum urea and creatinine, as well as kidney size, were measured in 50 patients with HFRS during the HFRS outbreak in B&H in 2002. The enlargement of both kidneys was found in all patients. The serum creatinine and urea levels were significantly higher in DOBV compared to PUUV patients. Acute haemodialysis treatment was necessary in 28% of the DOBV and in none of the PUUV patients. The authors did not observe significant differences in the mean diuresis values in DOBV compared to PUUV patients. In contrast, our results show a significant difference in diuresis values between different hantavirus serotypes. DOBV patients in our study had significantly lower diuresis values compared to PUUV, which can be explained with the larger study sample of patients included in this investigation. Reports from Croatia also associated DOBV infection with more severe disease than PUUV infection, but also confirmed previous findings that even PUUV infection could lead to severe disease [13, 14, 17] . Markotić et al. [17] observed that a significantly higher proportion of DOBV-infected patients had acute renal failure, visual disturbance, severe thrombocytopaenia and elevated levels of non-segmented leukocytes, creatine and total bilirubin.
HFRS is a zoonosis with sudden onset, characterised by high fever, renal insufficiency and haemorrhages. The basic pathologic and pathophysiologic disorder in HFRS is capillary damage (vasculitis). HFRS manifests depending, in part, on the causative virus as a mild, moderate or severe disease [2] . The course of HFRS is usually divided into five distinct stages; febrile, hypotensive, oliguric, polyuric and convalescent. The febrile stage with sudden onset usually lasts from 3 to 7 days. The hypotensive stage lasts from 1 to 2 days on an average and is characterised by lower blood pressure and signs of renal failure. During the oliguric stage, extensive haemorrhage may occur and the urea and creatinine levels reach their highest values, followed by the polyuric stage [18] .
Tulumovic et al. [12] in their study followed up 45 HFRS patients for 10 years and found that DOBVseropositive patients had, although within normal reference values, significantly lower glomerular filtration rates compared to PUUV patients.
Interestingly, 24.2% of the patients with typical clinical symptoms of HFRS expressed antibodies for a hantavirus which showed no preferential activity with one of the antigens present in the currently available commercial tests. The inability to define the hantaviral serotype in symptomatic subjects could be due to the antigenic similarities among hantaviruses and cross-reactivity during the acute stage of HFRS. In serological assays, cross-reactivity is frequently seen. These cross-reactions may disturb the interpretation of serological results in diagnostic work. Neutralisation tests were not applied because they are not available in B&H. The option of obtaining neutralisation test data abroad was ruled out because of stringent export procedures for biological materials.
However, in our study, 12.7% of 63 asymptomatic healthy subjects expressed hantaviral IgG antibodies that could not be identified with commercially available PUUV, HTNV, DOBV and SEOV antigens. The occurrence of antibodies for a hantavirus that cannot be identified with the currently used tests both in symptomatic HFRS patients and in asymptomatic subjects implicate that further studies are needed to possibly identify another hantavirus which might be endemic throughout the Balkans.
Conclusion
Our study findings show the circulation of Puumala (PUUV) and Dobrava (DOBV) viruses in haemorrhagic fever with renal syndrome (HFRS) patients and in asymptomatic hantavirus antibody-positive subjects in Bosnia and Herzegovina (B&H). PUUV seroreactivity is more prevalent in asymptomatic subjects compared to HFRS patients. In HFRS patients, DOBV is associated with severe renal impairment during the acute stage of the illness. These findings suggest that PUUV is less virulent and that PUUV causes inapparent or mild infection not necessitating hospitalisation.
